Diabetes eye screening in urban settings serving minority populations: detection of diabetic retinopathy and other ocular findings using telemedicine
- PMID: 25393129
- PMCID: PMC4479273
- DOI: 10.1001/jamaophthalmol.2014.4652
Diabetes eye screening in urban settings serving minority populations: detection of diabetic retinopathy and other ocular findings using telemedicine
Erratum in
-
Omission in article information.JAMA Ophthalmol. 2015 May;133(5):621. doi: 10.1001/jamaophthalmol.2015.1176. JAMA Ophthalmol. 2015. PMID: 25974651 No abstract available.
Abstract
Importance: The use of a nonmydriatic camera for retinal imaging combined with the remote evaluation of images at a telemedicine reading center has been advanced as a strategy for diabetic retinopathy (DR) screening, particularly among patients with diabetes mellitus from ethnic/racial minority populations with low utilization of eye care.
Objective: To examine the rate and types of DR identified through a telemedicine screening program using a nonmydriatic camera, as well as the rate of other ocular findings.
Design, setting, and participants: A cross-sectional study (Innovative Network for Sight [INSIGHT]) was conducted at 4 urban clinic or pharmacy settings in the United States serving predominantly ethnic/racial minority and uninsured persons with diabetes. Participants included persons aged 18 years or older who had type 1 or 2 diabetes mellitus and presented to the community-based settings.
Main outcomes and measures: The percentage of DR detection, including type of DR, and the percentage of detection of other ocular findings.
Results: A total of 1894 persons participated in the INSIGHT screening program across sites, with 21.7% having DR in at least 1 eye. The most common type of DR was background DR, which was present in 94.1% of all participants with DR. Almost half (44.2%) of the sample screened had ocular findings other than DR; 30.7% of the other ocular findings were cataract.
Conclusions and relevance: In a DR telemedicine screening program in urban clinic or pharmacy settings in the United States serving predominantly ethnic/racial minority populations, DR was identified on screening in approximately 1 in 5 persons with diabetes. The vast majority of DR was background, indicating high public health potential for intervention in the earliest phases of DR when treatment can prevent vision loss. Other ocular conditions were detected at a high rate, a collateral benefit of DR screening programs that may be underappreciated.
Figures
Similar articles
-
Patients' Adherence to Recommended Follow-up Eye Care After Diabetic Retinopathy Screening in a Publicly Funded County Clinic and Factors Associated With Follow-up Eye Care Use.JAMA Ophthalmol. 2016 Nov 1;134(11):1221-1228. doi: 10.1001/jamaophthalmol.2016.3081. JAMA Ophthalmol. 2016. PMID: 27632231
-
Evaluation of Diabetic Retinal Screening and Factors for Ophthalmology Referral in a Telemedicine Network.JAMA Ophthalmol. 2017 Jul 1;135(7):706-714. doi: 10.1001/jamaophthalmol.2017.1150. JAMA Ophthalmol. 2017. PMID: 28520833 Free PMC article.
-
Use of Telehealth Screening to Detect Diabetic Retinopathy and Other Ocular Findings in Primary Care Settings.Telemed J E Health. 2019 Sep;25(9):802-807. doi: 10.1089/tmj.2018.0016. Epub 2018 Nov 27. Telemed J E Health. 2019. PMID: 30481134
-
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD013775. doi: 10.1002/14651858.CD013775.pub2. Cochrane Database Syst Rev. 2023. PMID: 36815723 Free PMC article. Review.
-
Ocular telemedicine for diabetic retinopathy and the Joslin Vision Network.Semin Ophthalmol. 2010 Sep-Nov;25(5-6):218-24. doi: 10.3109/08820538.2010.518893. Semin Ophthalmol. 2010. PMID: 21091003 Review.
Cited by
-
Early diagnostics and interventional glaucoma.Ther Adv Ophthalmol. 2024 Oct 13;16:25158414241287431. doi: 10.1177/25158414241287431. eCollection 2024 Jan-Dec. Ther Adv Ophthalmol. 2024. PMID: 39421852 Free PMC article. Review.
-
Follow-up in a point-of-care diabetic retinopathy program in Pittsburgh: a non-concurrent retrospective cohort study.BMC Ophthalmol. 2024 Aug 20;24(1):356. doi: 10.1186/s12886-024-03581-9. BMC Ophthalmol. 2024. PMID: 39164678 Free PMC article.
-
Comprehensive insights into a decade-long journey: The evolution, impact, and human factors of an asynchronous telemedicine program for diabetic retinopathy screening in Pennsylvania, United States.PLoS One. 2024 Jul 12;19(7):e0305586. doi: 10.1371/journal.pone.0305586. eCollection 2024. PLoS One. 2024. PMID: 38995899 Free PMC article.
-
Ocular biomarkers: useful incidental findings by deep learning algorithms in fundus photographs.Eye (Lond). 2024 Sep;38(13):2581-2588. doi: 10.1038/s41433-024-03085-2. Epub 2024 May 11. Eye (Lond). 2024. PMID: 38734746 Free PMC article.
-
Teleophthalmology provides earlier eye care access for patients with newly-diagnosed diabetes.Heliyon. 2024 Feb 10;10(4):e25845. doi: 10.1016/j.heliyon.2024.e25845. eCollection 2024 Feb 29. Heliyon. 2024. PMID: 38384560 Free PMC article.
References
-
- Centers for Disease Control and Prevention . National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States. US Department of Health and Human Services; Atlanta GA: 2014. http://www.cdc.gov/diabetes/pubs/statsreport14.htm.
-
- Boyle JP, Honeycutt AA, Narayan KM, et al. Projection of diabetes burden through 2050. Diabetes Care. 2001;24:1936–1940. - PubMed
-
- Saaddine JB, Honeycutt AA, Narayan KM, Zhang X, Klein R, Boyle JP. Projection of diabetic retinopathy and other major eye diseaes among people with diabetes mellitus: United States, 2005-2050. Arch Ophthalmol. 2008;126:1740–1747. - PubMed
-
- Rein D, Zhang P, Wirth K, et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol. 2006;124:1754–1760. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U58 DP002655/DP/NCCDPHP CDC HHS/United States
- 5U58DP002652/DP/NCCDPHP CDC HHS/United States
- U58DP002652/ACL/ACL HHS/United States
- 5U58DP002653/DP/NCCDPHP CDC HHS/United States
- U58 DP002653/DP/NCCDPHP CDC HHS/United States
- U58DP002653/ACL/ACL HHS/United States
- P30 DK079626/DK/NIDDK NIH HHS/United States
- 5U58DP002655/DP/NCCDPHP CDC HHS/United States
- U58 DP002652/DP/NCCDPHP CDC HHS/United States
- 5U58DP002651/DP/NCCDPHP CDC HHS/United States
- U01 DP005127/DP/NCCDPHP CDC HHS/United States
- U58 DP002651/DP/NCCDPHP CDC HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
